形腺瘤的恶性转变:DNA甲基化分析和致病突变的影响
Emmanuelle Uro-Coste1, Yvan Nicaise2, Béatrice Akiki3
1CRCT, Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France; UFR Santé, Université de Toulouse III-Paul Sabatier, Toulouse, France; Toulouse University Hospital, Pathology department, Toulouse, France.
概括
通过DNA甲基化分析,可以区分良性多形腺瘤 (PA) 和恶性癌症前多形腺瘤 (CXPA). 特定基因突变和染色体变异是唾液腺瘤恶性转变的关键指标.
科学领域:
- 在瘤学瘤学.
- 分子病理学分子病理学
- 遗传学 是一个遗传学.
背景情况:
- 唾液腺瘤是罕见的和多样化的,形腺瘤 (PA) 是最常见的.
- 恶性转化PA到癌前形腺瘤 (CXPA) 是一个复杂的过程.
- 由于主观的病理评估,区分非典型的PA和低级CXPA具有挑战性.
研究的目的:
- 研究DNA甲基化分析作为分辨PA与CXPA的分子工具.
- 识别与唾液腺瘤恶性转变相关的分子特征.
主要方法:
- 140个PA和CXPA病例的未来收集.
- 在33个PA和33个CXPA病例中进行了DNA甲基化分析.
- 对TP53,HRAS,PTEN,TERT突变和染色体变化的分析.
主要成果:
- 根据甲基化概况,PA和CXPA病例被分为三种不同的群体:良性,中性和恶性.
- 在TP53,HRAS,PTEN和/或TERT的致病突变仅在CXPA病例中发现.
- 染色体5和8染色体的染色体变化与恶性转变有关.
结论:
- DNA甲基化分析为PA-CXPA谱中分类唾液腺瘤提供了一个分子框架.
- 识别TP53,HRAS,PTEN,TERT或HER2放大基因突变可以帮助对CXPA进行分子诊断.
- 未来的发展旨在建立甲基组分类作为PA-CXPA管理的精密药物诊断工具.
相关概念视频
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Epigenetic Regulation
2.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
2.9K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Cancers Originate from Somatic Mutations in a Single Cell
11.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K
Mismatch Repair
4.6K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.6K
Induced Pluripotent Stem Cells
3.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.8K


